Showing 201 - 220 results of 69,802 for search '(( 5 ((((ng decrease) OR (a decrease))) OR (nn decrease)) ) OR ( 20 we decrease ))', query time: 0.90s Refine Results
  1. 201
  2. 202

    DataSheet_1_Accelerating Decreases in the Incidences of Hepatocellular Carcinoma at a Younger Age in Shanghai Are Associated With Hepatitis B Virus Vaccination.docx by Shunzhang Yu (12340927)

    Published 2022
    “…Sero-epidemiological data from the sampling surveys during 20 years of follow-up showed that less than 1% of people undergoing HBV vaccination have a positive serum HBsAg. …”
  3. 203
  4. 204
  5. 205

    Table_5_Pathogenesis of Enamel-Renal Syndrome Associated Gingival Fibromatosis: A Proteomic Approach.pdf by Victor Simancas Escorcia (9741794)

    Published 2021
    “…ERS is caused by bi-allelic mutations in the secretory pathway pseudokinase FAM20A. How mutations in FAM20A may modify the gingival connective tissue homeostasis and cause fibromatosis is currently unknown. …”
  6. 206
  7. 207
  8. 208
  9. 209
  10. 210
  11. 211
  12. 212

    Fig 1 - by Byung Chul Kang (1905025)

    Published 2023
    Subjects:
  13. 213
  14. 214
  15. 215
  16. 216

    Data_Sheet_5_Decreased default mode network functional connectivity with visual processing regions as potential biomarkers for delayed neurocognitive recovery: A resting-state fMRI study and machine-learning analysis.ZIP by Zhaoshun Jiang (7478243)

    Published 2023
    “…The algorithm performance was evaluated by a permutation test.</p>Results<p>We found significantly decreased DMN connectivity with the brain regions involved in visual processing in DNR patients than in non-DNR patients. …”
  17. 217

    Decreased antihyperglycemic drug use driven by high out-of-pocket costs despite Medicare coverage gap closure by Mugdha Gokhale (8676201)

    Published 2020
    “…<a><b>Objectives</b></a>: <a>Using the 2016 Medicare part D coverage gap as an example, we explored effects of increased out-of-pocket costs on adherence to branded </a>dipeptidyl peptidase-4 inhibitors (DPP-4i) in patients without financial subsidies, relative to subsidized patients who do not experience increased spending during the gap. …”
  18. 218
  19. 219
  20. 220